Dishman Carbogen Amcis Limited
NSE: DCAL · Healthcare
₹172.05
-1.20 (-0.69%)
Last close · 30 Aug 2026, 7:16 am IST
- Open
- ₹174.75
- Day high
- ₹174.75
- Day low
- ₹170.90
- Volume
- 1.81 L
- Prev close
- ₹173.25
Price chart
Range
EMA
Also show
Fundamentals
Biotechnology
Valuation
- Market Cap
- 2,878 Cr
- Price
- 183.58
- P/E (TTM)
- 29.51
- P/E (Fwd)
- 14.69
- P/B
- 0.43
- EV/EBITDA
- 8.73
- EV/Revenue
- 1.69
- PEG
- —
- Div Yield
- —
- 52W High
- 321.95
- 52W Low
- 128.50
- Beta
- 0.62
Profitability & income
- Revenue (TTM)
- 2,932 Cr
- Net Income (TTM)
- 97 Cr
- EBITDA
- 566 Cr
- Gross Margin
- 86.06%
- Op. Margin
- 8.71%
- Net Margin
- 3.32%
- ROE
- 1.56%
- ROA
- 1.29%
- EPS (TTM)
- 6.22
- EPS (Fwd)
- 12.50
Financial health
- Total Debt
- 3,076 Cr
- Total Cash
- 1,007 Cr
- Debt/Equity
- 46.07
- Current Ratio
- 1.23
- Quick Ratio
- 0.73
- Book Value
- 426.90
- Free Cash Flow
- 31 Cr
- Op. Cash Flow
- 491 Cr
Growth
- Revenue Growth
- 18.90%
- Earnings Growth
- -49.50%
- Earnings QoQ
- -49.50%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 851 Cr | 22 Cr | 178 Cr | 74 Cr | 716 Cr | — | 3,076 Cr | 6,677 Cr |
| 2025-12-31 | 720 Cr | -13 Cr | 120 Cr | 29 Cr | 578 Cr | — | — | — |
| 2025-06-30 | 708 Cr | 23 Cr | 163 Cr | 59 Cr | 610 Cr | — | — | — |
| 2025-03-31 | 716 Cr | 43 Cr | 149 Cr | 74 Cr | 570 Cr | — | 2,389 Cr | 5,832 Cr |
| 2024-12-31 | 682 Cr | 5 Cr | 148 Cr | 68 Cr | 584 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,932 Cr | 97 Cr | 618 Cr | 227 Cr | 2,523 Cr | 491 Cr | 3,076 Cr | 6,677 Cr |
| 2025-03-31 | 2,712 Cr | 3 Cr | 473 Cr | 175 Cr | 2,210 Cr | 371 Cr | 2,389 Cr | 5,832 Cr |
| 2024-03-31 | 2,544 Cr | -153 Cr | 302 Cr | -41 Cr | 1,932 Cr | 379 Cr | 2,313 Cr | 5,628 Cr |
| 2023-03-31 | 2,315 Cr | -30 Cr | 301 Cr | 105 Cr | 1,781 Cr | 266 Cr | 2,209 Cr | 5,810 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for DCAL?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in